(Q39253982)

10 September 2017

title

High-Content Assessment of Cardiac Function Using Heart-on-a-Chip Devices as Drug Screening Model (English)

1 reference

10 September 2017

0 references

Genevieve Conant

1

1 reference

10 September 2017

Benjamin Fook Lun Lai

2

1 reference

10 September 2017

Rick Xing Ze Lu

3

1 reference

10 September 2017

Anastasia Korolj

4

1 reference

10 September 2017

Erika Yan Wang

5

1 reference

10 September 2017

Milica Radisic

6

1 reference

10 September 2017

publication date

20 April 2017

1 reference

Stem Cell Reviews and Reports

10 September 2017

published in

1 reference

10 September 2017

volume

13

1 reference

10 September 2017

issue

3

1 reference

10 September 2017

page(s)

335-346

1 reference

Innovation in the pharmaceutical industry: New estimates of R&D costs

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

21 January 2018

2014 FDA drug approvals

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Can the pharmaceutical industry reduce attrition rates?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Trial watch: phase II and phase III attrition rates 2011-2012.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Tri-iodo-l-thyronine promotes the maturation of human cardiomyocytes-derived from induced pluripotent stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Functional assembly of engineered myocardium by electrical stimulation of cardiac myocytes cultured on scaffolds

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Tissue-engineered cardiac patch for advanced functional maturation of human ESC-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Biowire: a platform for maturation of human pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Human pluripotent stem cells: Prospects and challenges as a source of cardiomyocytes for in vitro modeling and cell-based cardiac repair.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

21 January 2018

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Hallmarks of Cancer: The Next Generation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

The protein kinase complement of the human genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Activation of tyrosine kinases in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Mutations of the BRAF gene in human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

BCR/ABL: from molecular mechanisms of leukemia induction to treatment of chronic myelogenous leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

The emerging normal and disease-related roles of anaplastic lymphoma kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Mechanisms of cardiac dysfunction associated with tyrosine kinase inhibitor cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiotoxicity of kinase inhibitors: the prediction and translation of preclinical models to clinical outcomes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Effect of the multitargeted tyrosine kinase inhibitors imatinib, dasatinib, sunitinib, and sorafenib on mitochondrial function in isolated rat heart mitochondria and H9c2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

ERBB2 triggers mammalian heart regeneration by promoting cardiomyocyte dedifferentiation and proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

ErbB2 is essential in the prevention of dilated cardiomyopathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Conditional mutation of the ErbB2 (HER2) receptor in cardiomyocytes leads to dilated cardiomyopathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Glycogen synthase kinase-3beta: a novel regulator of cardiac hypertrophy and development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Distinct roles of GSK-3alpha and GSK-3beta phosphorylation in the heart under pressure overload

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Blockade of the erbB2 receptor induces cardiomyocyte death through mitochondrial and reactive oxygen species-dependent pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

The GSK-3 family as therapeutic target for myocardial diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiotoxicity induced by tyrosine kinase inhibitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Molecular mechanisms of cardiotoxicity of tyrosine kinase inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Risk of heart failure in breast cancer patients after anthracycline and trastuzumab treatment: a retrospective cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiotoxicity associated with the cancer therapeutic agent sunitinib malate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Mechanisms of myocyte cytotoxicity induced by the multiple receptor tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiac toxicity of sunitinib and sorafenib in patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Impact of high-throughput screening in biomedical research

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiotoxicity testing using pluripotent stem cell-derived human cardiomyocytes and state-of-the-art bioanalytics: a review.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Improved functional expression of recombinant human ether-a-go-go (hERG) K+ channels by cultivation at reduced temperature

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Species plays an important role in drug-induced prolongation of action potential duration and early afterdepolarizations in isolated Purkinje fibers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

High purity human-induced pluripotent stem cell-derived cardiomyocytes: electrophysiological properties of action potentials and ionic currents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Drug screening using a library of human induced pluripotent stem cell-derived cardiomyocytes reveals disease-specific patterns of cardiotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

The long QT syndrome: ion channel diseases of the heart

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Increased risk of arrhythmic events in long-QT syndrome with mutations in the pore region of the human ether-a-go-go-related gene potassium channel

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

High throughput screening technologies for ion channels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Prediction of drug-induced cardiotoxicity using human embryonic stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Comparison of electrophysiological data from human-induced pluripotent stem cell-derived cardiomyocytes to functional preclinical safety assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Patterned cardiomyocytes on microelectrode arrays as a functional, high information content drug screening platform

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Multiparameter in vitro assessment of compound effects on cardiomyocyte physiology using iPSC cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Assessment of cardiomyocyte contraction in human-induced pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

High-Content Assay Multiplexing for Toxicity Screening in Induced Pluripotent Stem Cell-Derived Cardiomyocytes and Hepatocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Real-time measurement of the contractile forces of self-organized cardiomyocytes on hybrid biopolymer microcantilevers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Ensembles of engineered cardiac tissues for physiological and pharmacological study: heart on a chip

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Functional maturation of human pluripotent stem cell derived cardiomyocytes in vitro--correlation between contraction force and electrophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Developments in three-dimensional cell culture technology aimed at improving the accuracy of in vitro analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Dynamic transcription factor activity profiling in 2D and 3D cell cultures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Drug-screening platform based on the contractility of tissue-engineered muscle.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Muscular thin films for building actuators and powering devices.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Development of a drug screening platform based on engineered heart tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Human engineered heart tissue as a versatile tool in basic research and preclinical toxicology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

High-content drug screening with engineered musculoskeletal tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Engineering adolescence: maturation of human pluripotent stem cell-derived cardiomyocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Application of blebbistatin as an excitation-contraction uncoupler for electrophysiologic study of rat and rabbit hearts.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Pluripotent stem cell-derived cardiac tissue patch with advanced structure and function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

The role of extracellular matrix composition in structure and function of bioengineered skeletal muscle

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Macroporous nanowire nanoelectronic scaffolds for synthetic tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Engineered hybrid cardiac patches with multifunctional electronics for online monitoring and regulation of tissue function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Printable elastic conductors with a high conductivity for electronic textile applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

OptoDyCE as an automated system for high-throughput all-optical dynamic cardiac electrophysiology.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Advances in tissue engineering through stem cell-based co-culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Growth of engineered human myocardium with mechanical loading and vascular coculture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Design and formulation of functional pluripotent stem cell-derived cardiac microtissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

How can we improve our understanding of cardiovascular safety liabilities to develop safer medicines?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Current challenges in the evaluation of cardiac safety during drug development: translational medicine meets the Critical Path Initiative

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

HeLiVa platform: integrated heart-liver-vascular systems for drug testing in human health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

μOrgano: A Lego®-Like Plug & Play System for Modular Multi-Organ-Chips

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Micro Total Bioassay System for Ingested Substances: Assessment of Intestinal Absorption, Hepatic Metabolism, and Bioactivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Characterization of a gastrointestinal tract microscale cell culture analog used to predict drug toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

A micro cell culture analog (microCCA) with 3-D hydrogel culture of multiple cell lines to assess metabolism-dependent cytotoxicity of anti-cancer drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Towards a human-on-chip: culturing multiple cell types on a chip with compartmentalized microenvironments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Organs-on-a-chip: a new tool for drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

The role of body-on-a-chip devices in drug and toxicity studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

On being the right size: scaling effects in designing a human-on-a-chip.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Engineering challenges for instrumenting and controlling integrated organ-on-chip systems

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Maturing human pluripotent stem cell-derived cardiomyocytes in human engineered cardiac tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

In vitro models for liver toxicity testing

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiotoxicity associated with tyrosine kinase inhibitor sunitinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

An evaluation of the cardiotoxicity of imatinib mesylate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiotoxicity of the cancer therapeutic agent imatinib mesylate.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Increased cardiotoxicity of sorafenib in sunitinib-pretreated patients with metastatic renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Could erlotinib treatment lead to acute cardiovascular events in patients with lung adenocarcinoma after chemotherapy failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Clinical cardiac safety profile of nilotinib

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12015-017-9736-2

Cardiotoxicity of trastuzumab in clinical practice

21 January 2018

1 reference

12 December 2020

Simultaneous measurement of Ca2+, contraction, and potential in cardiac myocytes

1 reference

12 December 2020

Trastuzumab-induced cardiotoxicity: heart failure at the crossroads

1 reference

12 December 2020

Tyrosine kinases as targets for cancer therapy

1 reference

12 December 2020

Instrumented cardiac microphysiological devices via multimaterial three-dimensional printing

1 reference

12 December 2020

Simple and Versatile 3D Printed Microfluidics Using Fused Filament Fabrication

1 reference

12 December 2020

Vascular endothelial growth factor expression is increased in renal cell carcinoma

1 reference

12 December 2020

Assessment of Cardiac Dysfunction in a Randomized Trial Comparing Doxorubicin and Cyclophosphamide Followed by Paclitaxel, With or Without Trastuzumab As Adjuvant Therapy in Node-Positive, Human Epidermal Growth Factor Receptor 2–Overexpressing Bre

1 reference

12 December 2020

Highly conductive, printable and stretchable composite films of carbon nanotubes and silver

1 reference

12 December 2020

Recurrent myocardial infarction associated with gefitinib therapy

1 reference

12 December 2020

Lapatinib in breast cancer

1 reference

12 December 2020

Akt1 is required for physiological cardiac growth

1 reference

12 December 2020

A microfabricated platform to measure and manipulate the mechanics of engineered cardiac microtissues

1 reference

12 December 2020

How to improve R&D productivity: the pharmaceutical industry's grand challenge

1 reference

12 December 2020

Analysis of Tyrosine Kinase Inhibitor-Mediated Decline in Contractile Force in Rat Engineered Heart Tissue

1 reference

12 December 2020

10.1007/S12015-017-9736-2

Identifiers

DOI

1 reference

10 September 2017

1 reference